Christopher J. Jensen is CRO at Ibotta, Inc. (IBTA). They have made 1 open-market trade across 1 company since 2024, most recently 2024-06-05.
CIK 0002017916
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IBTA | 107,662 | $5.2M |
Shares reported on the most recent Form 4, priced at the 2024-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IBTA | SELL | 2024-04-22 | 2024-04-22 | $88.00 | $2.3M | +3.8% | +3.8% | -34.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.